Article Text

Download PDFPDF
Original article
Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up
  1. Alfredo Pece1,
  2. Vincenzo Isola1,
  3. Stefano Piermarocchi2,
  4. Giliola Calori3
  1. 1Department of Ophthalmology, Melegnano Hospital, Milan, Italy
  2. 2Department of Ophthalmology, University of Padua, Padua, Italy
  3. 3Statistics and Epidemiology Unit, San Raffaele University Hospital, Milan, Italy
  1. Correspondence to Dr Alfredo Pece, Department of Ophthalmology, Melegnano Hospital, Via Pandina 1, 20077 Vizzolo Predabissi, Milan, Italy; pece.retina{at}mclink.it

Footnotes

  • Presented as a paper at the Annual AAO/SOI Joint Meeting, Atlanta, USA, 8–11 November 2008.

  • Funding Supported by Fondazione Retina 3000 Milan.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Presented as a paper at the Annual AAO/SOI Joint Meeting, Atlanta, USA, 8–11 November 2008.

  • Funding Supported by Fondazione Retina 3000 Milan.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Harminder S Dua Arun D Singh